/Investor DB

Bering Capital

Venture capitalActively deploying

San Francisco · Seed–Late Stage · 8 people tracked

Find your way into Bering Capital

Sign up to see every warm intro you have to Bering Capital

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Bering Capital team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Bering Capital backs exceptional founders building cutting-edge biotech and medical technology companies, guided by a belief in the importance of great markets aligned with great people. Drawing on lessons learned from early Silicon Valley and venture capital pioneers, as well as its own entrepreneurial experience, the firm focuses on identifying critical problems and acting at the right moment. It emphasizes shaping a company's early DNA to position it for success, aiming to help transform groundbreaking ideas into world-class companies.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
HQ
San Francisco, California, US
Instruments
Equity
Founded
2020
Tracked investments
1

Team · 8 people

from the firm's website & curated & public directories
Evgeny Zaytsev· Managing Partner

Managing Partner at Bering Capital, holding MD and PhD credentials.

Philip Sawyer· Managing Partnerin

Managing Partner at Bering Capital.

Christopher Alafi· Advisor

Advisor to Bering Capital, holding a DPhil.

George Painter· Advisor

Advisor to Bering Capital, holding a PhD.

Gregory B. Brown· Advisor

Advisor to Bering Capital, holding an MD.

Stephen A. Sherwin· Advisor

Advisor to Bering Capital, holding an MD.

What they invest in

from 1 of 1 portfolio companies

Biotech ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
OncoResponseoncoresponseinc.comMay 2023 · $14M

Clinical-stage immuno-oncology company developing antibodies derived from the immune systems of 'Elite' cancer responders.

BiotechHouston, US

Alice Bexon(Executive Officer)inClifford J. Stocks(Director, Executive Officer)inKamal D. Puri(Executive Officer)inChris Russell(Executive Officer)inRuss Hawkinson(Executive Officer)

BoardSteven Gillis(Director)in

Co-investors3B Future Health FundCanaan PartnersGreatPoint VenturesRiverVest Venture PartnersAlexandriaARCH Venture Partners+5 more

Frequently asked questions

What stage does Bering Capital invest at?
Bering Capital invests at the Seed, Series A, Late Stage stages.
What sectors does Bering Capital focus on?
Bering Capital focuses on Biotech, Healthtech, Medical Devices.
Where is Bering Capital located?
Bering Capital is headquartered in San Francisco, US.

Images

Bering Capital photo

Similar investors

Featured in lists